These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 3014736

  • 41. Inhibition of thrombin in plasma by heparin or arginine.
    Stief TW.
    Clin Appl Thromb Hemost; 2007 Apr; 13(2):146-53. PubMed ID: 17456623
    [Abstract] [Full Text] [Related]

  • 42. Antimicrobial activity of fibrinogen and fibrinogen-derived peptides--a novel link between coagulation and innate immunity.
    Påhlman LI, Mörgelin M, Kasetty G, Olin AI, Schmidtchen A, Herwald H.
    Thromb Haemost; 2013 May; 109(5):930-9. PubMed ID: 23467586
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Biochemical and hemostatic mechanism of a novel thrombin-like enzyme.
    Tang SS, Zhang JH, Tang BS, Tang ZH, Li HZ, Yuan HJ, Chui SL, Zhao EY.
    Thromb Res; 2009 Nov; 124(5):631-9. PubMed ID: 19683796
    [Abstract] [Full Text] [Related]

  • 45. The effect of prophylactic heparin treatment on enhanced thrombin generation in pregnancy.
    Bremme K, Lind H, Blombäck M.
    Obstet Gynecol; 1993 Jan; 81(1):78-83. PubMed ID: 8416465
    [Abstract] [Full Text] [Related]

  • 46. Duvernoy's gland secretion of Philodryas patagoniensis from the northeast of Argentina: its effects on blood coagulation.
    Peichoto ME, Leiva LC, Guaimás Moya LE, Rey L, Acosta O.
    Toxicon; 2005 Mar 15; 45(4):527-34. PubMed ID: 15733575
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Sensitivity of the fibrinogen clotting time: an in vitro test of potential thrombogenicity.
    Feldman PA, McGrath S, Evans H.
    Vox Sang; 1994 Mar 15; 66(1):1-7. PubMed ID: 8146976
    [Abstract] [Full Text] [Related]

  • 51. Enhanced binding of fibrinogen by the subendothelium after treatment of the rabbit aorta with thrombin.
    Hatton MW, Moar SL, Richardson M.
    J Lab Clin Med; 1990 Mar 15; 115(3):356-64. PubMed ID: 2138206
    [Abstract] [Full Text] [Related]

  • 52. Bothrojaracin: a potent two-site-directed thrombin inhibitor.
    Arocas V, Zingali RB, Guillin MC, Bon C, Jandrot-Perrus M.
    Biochemistry; 1996 Jul 16; 35(28):9083-9. PubMed ID: 8703912
    [Abstract] [Full Text] [Related]

  • 53. [Changes in the blood coagulation and anticoagulation system against a background of narcosis and ganglionic block].
    Seit-Umerov SM, Poliukhov SM, Obydennikova TN.
    Vestn Khir Im I I Grek; 1969 Aug 16; 103(8):16-9. PubMed ID: 4394393
    [No Abstract] [Full Text] [Related]

  • 54. [The state of anticoagulant system of animals following injections of purified thrombin and N-acetyl-thrombin].
    Kudriashov BA, BASKOVA IP, Orlova AS, Kuznetsova-Fogt Kj.
    Fiziol Zh SSSR Im I M Sechenova; 1976 Apr 16; 62(4):559-65. PubMed ID: 1278533
    [Abstract] [Full Text] [Related]

  • 55. [Effect of thrombomodulin on specific thrombin functions: fibrinogen coagulation and thrombocyte aggregation].
    Luk'ianenko EF, Kireeva EG, Strukova SM.
    Biull Eksp Biol Med; 1988 Nov 16; 106(11):517-9. PubMed ID: 2848597
    [Abstract] [Full Text] [Related]

  • 56. [The modification of the effect of trypsin on blood coagulation by natural and synthetic trypsin and thrombin inhibitors].
    Landman H, Markwardt F, Perlewitz J.
    Thromb Diath Haemorrh; 1969 Dec 31; 22(3):552-68. PubMed ID: 5382290
    [No Abstract] [Full Text] [Related]

  • 57. [Presence of an active fibrinogen--heparin complex in the total blood plasma fraction of plasma fibrinogen degradation products].
    Kudriashov BA, Liapina LA, Ul'ianov AM.
    Biokhimiia; 1977 Mar 31; 42(3):451-9. PubMed ID: 861306
    [Abstract] [Full Text] [Related]

  • 58. Effect of activated human protein C on disseminated intravascular coagulation induced by lipopolysaccharide in rats.
    Aoki Y, Ota M, Katsuura Y, Komoriya K, Nakagaki T.
    Arzneimittelforschung; 2000 Sep 31; 50(9):809-15. PubMed ID: 11050697
    [Abstract] [Full Text] [Related]

  • 59. The characteristics of anticoagulation by covalently immobilized heparin.
    Miura Y, Aoyagi S, Kusada Y, Miyamoto K.
    J Biomed Mater Res; 1980 Sep 31; 14(5):619-30. PubMed ID: 7349668
    [Abstract] [Full Text] [Related]

  • 60. Fibrinogen assay during heparin therapy of disseminated intravascular coagulation.
    Foster LB, Frings CS, Hochholzer JM.
    Clin Chem; 1971 Dec 31; 17(12):1216. PubMed ID: 5118165
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.